Genetic Polymorphisms of CFH and ARMS2 Do Not Predict Response to Antioxidants and Zinc in Patients with Age-Related Macular Degeneration

Considerable controversy has erupted in recent years regarding whether genotyping should be part of standard care for patients with age-related macular degeneration (AMD) who are being considered for treatment with antioxidants and zinc. We aimed to determine whether genotype predicts response to supplements in AMD.

http://www.aaojournal.org/article/S0161-6420(17)32345-X/fulltext?rss=yes

Source: Ophthalmology - October 9, 2017 Category: Opthalmology Authors: Melissa J. Assel, Fan Li, Ying Wang, Andrew S. Allen, Keith A. Baggerly, Andrew J. Vickers Source Type: research

More News: Age-Related Macular Degeneration (AMD) | Genetics | Opthalmology | Zinc